434 related articles for article (PubMed ID: 2573280)
1. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
2. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
[TBL] [Abstract][Full Text] [Related]
3. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
4. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
5. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
Jensen RT; Fraker DL
JAMA; 1994 May; 271(18):1429-35. PubMed ID: 7513768
[No Abstract] [Full Text] [Related]
6. Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.
Norton JA; Doppman JL; Jensen RT
Ann Surg; 1992 Jan; 215(1):8-18. PubMed ID: 1531004
[TBL] [Abstract][Full Text] [Related]
7. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Pisegna JR; Norton JA; Slimak GG; Metz DC; Maton PN; Gardner JD; Jensen RT
Gastroenterology; 1992 Mar; 102(3):767-78. PubMed ID: 1537514
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
Banasch M; Schmitz F
Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
10. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
11. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.
Pipeleers-Marichal M; Donow C; Heitz PU; Klöppel G
World J Surg; 1993; 17(4):481-8. PubMed ID: 8103250
[TBL] [Abstract][Full Text] [Related]
12. Studies with bombesin in the Zollinger--Ellison syndrome.
Basso N; Lezoche E; Materia A; Passaro E; Speranza V
Br J Surg; 1981 Feb; 68(2):97-100. PubMed ID: 7459630
[TBL] [Abstract][Full Text] [Related]
13. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
[TBL] [Abstract][Full Text] [Related]
14. Zollinger-Ellison syndrome and antral G-cell hyperfunction in patients with resistant duodenal ulcer disease.
Annibale B; De Magistris L; Corleto V; D'Ambra G; Marignani M; Iannoni C; Delle Fave G
Aliment Pharmacol Ther; 1994 Feb; 8(1):87-93. PubMed ID: 8186351
[TBL] [Abstract][Full Text] [Related]
15. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.
Frucht H; Howard JM; Slaff JI; Wank SA; McCarthy DM; Maton PN; Vinayek R; Gardner JD; Jensen RT
Ann Intern Med; 1989 Nov; 111(9):713-22. PubMed ID: 2572194
[TBL] [Abstract][Full Text] [Related]
16. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type I multiple endocrine neoplasia.
Ruszniewski P; Podevin P; Cadiot G; Marmuse JP; Mignon M; Vissuzaine C; Bonfils S; Lehy T
Pancreas; 1993 May; 8(3):295-304. PubMed ID: 8097874
[TBL] [Abstract][Full Text] [Related]
17. Abnormal pancreatic polypeptide release by secretin infusion in Zollinger-Ellison syndrome.
Rigaud D; Accary JP; Mignon M; Bonfils S
Dig Dis Sci; 1984 Aug; 29(8):696-702. PubMed ID: 6745029
[TBL] [Abstract][Full Text] [Related]
18. [Recent trend of diagnosis and treatment for Zollinger-Ellison syndrome].
Imamura M; Komoto I; Doi R
Gan To Kagaku Ryoho; 2005 Feb; 32(2):147-51. PubMed ID: 15751623
[TBL] [Abstract][Full Text] [Related]
19. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
[TBL] [Abstract][Full Text] [Related]
20. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
